Last reviewed · How we verify
NCT05218161
Hemodynamic Effect of Dexmedetomidine Alone With Dexmedetomidine Plus Ketamine Combination in CABG
NA trial testing Dexmedetomidine alone in Hemodynamic Instability in 40 participants. Status unknown.
1 February 2022
Quick facts
| Lead sponsor | Chaudhry Pervaiz Elahi Institute of Cardiology |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 40 |
| Start date | 1 January 2021 |
| Primary completion | 1 February 2022 |
| Estimated completion | 1 March 2022 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Dexmedetomidine alone — full drug profile →
Conditions studied
- Hemodynamic Instability — all drugs for Hemodynamic Instability →
Sponsor
Chaudhry Pervaiz Elahi Institute of Cardiology
Who can join
Adults 20 to 60, any sex, with Hemodynamic Instability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In post cardiac surgery, many cardiovascular and other complications may occur that lead to increase in mortality and hospital stays. Meticulous perioperative management is important to avoid these adverse events. Tachycardia is the main cause of post coronary artery bypass graft (CABG) myocardial ischemia which can be decreased by sedation and analgesia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05218161
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hemodynamic Instability
Currently open trials in the same condition.
- NCT07494955 — "Effect of Pre-Spinal Mindfulness-Based Breathing Exercise on Hemodynamic Response in Elective Cesarean Section" · NA · recruiting
- NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting
- NCT07246148 — NOn-inVAsive Blood Pressure Monitoring in Intracranial Aneurysm Embolization · NA · recruiting
- NCT06828575 — Evaluation of the Success of Artificial Intelligence Models in Interpreting Arterial Waveform Analysis Data · recruiting
- NCT05893420 — A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning · NA · active not recruiting
Other Chaudhry Pervaiz Elahi Institute of Cardiology trials
Trials by the same sponsor.
- NCT07251660 — Comparison of Early Postoperative Outcomes Between Minimally Invasive Valve Surgery Via Right Thoracotomy and Convention · NA · not yet recruiting
- NCT04700215 — Comparison of BiPAP and ٰIS in Reducing Post CABG Pulmonary Complications · NA · unknown
- NCT05290324 — Propofol or Midazolam for Sedation and Early Extubation Following Coronary Artery Bypass Graft Surgery · NA · completed
- NCT05004545 — Compare Hemodynamic Parameters of Propofol and Sevoflurane During CPB Time in Undergoing CABG to Avoid Lactate Level · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05218161 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chaudhry Pervaiz Elahi Institute of Cardiology
- Last refreshed: 1 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05218161.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing